RxDoctor Payments Data

Stephen Sherry

Endocrinology, Diabetes & Metabolism · Glen Ridge, NJNPI 1497856629

Payments from drug & device makers

$11,330in general payments, 2019–2025

Across 84 payments — averaging $134.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10K
  • Novo Nordisk$308
  • Amgen$162
  • Insulet Corporation$101
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$55
  • Shire North American Group Inc$54
  • plus $347 from 15 others

What the payments were for

  • Speaking & faculty fees$9,97588%
  • Travel & lodging$240%
  • Food & beverage$1,33112%

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,330 in reported general payments places this provider in the 80th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide148$188,021
JardianceEmpagliflozin102$99,533
FarxigaDapagliflozin Propanediol68$71,913
MounjaroTirzepatide12$23,678
TrulicityDulaglutide15$16,357
Levothyroxine Sodium219$3,328
Nano 2nd Gen Pen NeedlePen Needle, Diabetic31$3,133
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,528
SynthroidLevothyroxine Sodium31$2,025
Bromocriptine Mesylate12$1,177
Metformin Hcl81$820
Atorvastatin Calcium76$808
Metformin Hcl ErMetformin Hcl50$765
Rosuvastatin Calcium44$663
Pioglitazone Hcl38$458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$308$188,021148 claims
Boehringer IngelheimJardiance$28$99,533102 claims
AstraZenecaFarxiga$10,305$71,91368 claims
Lilly USA, LLCMounjaro, Trulicity$40$40,03527 claims
AbbVieSynthroid$14$2,02531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

Other endocrinology, diabetes & metabolism in Glen Ridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →